Clinical trial
Risedronate for the Prevention of Osteoporosis in People With Spinal Cord…
NCT00150696 · Toronto Rehabilitation Institute, Other · Completed
Key facts
| NCT number | NCT00150696 |
|---|---|
| Title | Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury. |
| Official title | Risedronate for Prevention of Osteoporosis After Spinal Cord Injury |
| Lead sponsor | Toronto Rehabilitation Institute, Other |
| Collaborators | Ontario Neurotrauma Foundation St. Joseph's Healthcare Foundation Queen Elizabeth Hospital NHS Foundation Trust |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Spinal Cord Injury. |
| Intervention type | Drug |
| Interventions | Risedronate |
| Enrollment | 38 |
| Start date | Feb 1, 2000 |
| Completion | Nov 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | Nov 21, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: